Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

According to the ministry, the scheme has facilitated the establishment of domestic manufacturing capabilities for a range of high-end medical devices that were earlier predominantly imported.

New Delhi: The Product Linked Incentive (PLI) scheme for medical devices has given a boost to local manufacturing of high-end medical technology devices, including MRI machines, CT Scanner and heart valves, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers said.

According to the ministry, production of 57 medical devices commenced under the scheme that were earlier predominantly imported. These include MRI machines, CT scanners, Cath Labs, Linear Accelerators, C-Arms, mammography machines, ultrasound systems, anaesthesia machines and heart valves.

The initiative has also attracted leading global manufacturers such as GE Healthcare, Siemens, Philips, Varex, Nipro and Omron and encouraged technology transfer and advanced manufacturing capabilities in India, the ministry added.

The PLI scheme with a total financial outlay of Rs 3,420 crore was launched in 2020 and provides a 5 per cent incentive on incremental sales of eligible medical devices manufactured in India for a period of five years.

It covers four broad segments, cancer care/radiotherapy medical devices; radiology and imaging devices; anaesthesia, cardio-respiratory and renal care devices; and implants, including implantable electronic devices, the ministry said.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs